中国学术期刊网络出版总库入编期刊
CNKI中文期刊全文数据库全文收录期刊
中国核心期刊(遴选)数据库全文收录期刊
万方数据——数字化期刊群收录期刊
中文科技期刊数据库全文收录期刊

主管:陕西省卫生健康委员会
主办:西安心身医学研究所
   西安交通大学第一附属医院
国际标准刊号:ISSN2096—1413
国内统一刊号:CN61—1503/R

奥曲肽联合奥美拉唑治疗肝硬化上消化道出血的临床疗效观察

陈先华,张宏涛

(陕西省商洛市城关镇卫生院,陕西商洛,726300)

浏览次数:83次 下载次数:415次

摘要:

目的 探究肝硬化上消化道出血患者应用奥曲肽和奥美拉唑治疗的效果。方法 选取90例肝硬化上消化道出血患者按治疗方法不同,分成两组,各45例,对照组给予奥曲肽治疗,观察组给予奥曲肽联合奥美拉唑联合治疗,观察两组的治疗效果。结果 观察组总有效率为97.78%,高于对照组80.00%(P<0.05);观察组住院时间、止血时间明显短于对照组(P<0.05);观察组术后再次出血发生率为2.22%,低于对照组的15.55%,差异有统计学意义(P<0.05)。结论 肝硬化上消化道出血患者应用奥曲肽和奥美拉唑治疗的疗效确切,可提升治疗有效率,缩短住院时间和止血时间,减少再次出血情况,值得临床推广应用。

关键词:奥曲肽;奥美拉唑;肝硬化上消化道出血

中图分类号:R587.1文献标志码:A文章编号:2096-1413(2017)07-0050-02

    Clinical effect of octreotide combined with omeprazole in the treatment of upper gastrointestinal bleeding in liver cirrhosis

    CHEN Xian-hua, ZHANG Hong-tao

    (Chengguan Town Hospitals, Shangluo 726300, China)

    ABSTRACT: Objective To investigate the efficacy of octreotide and omeprazole in the treatment of upper gastrointestinal bleeding in liver cirrhosis. Methods Ninety patients with cirrhosis of upper digestive tract hemorrhage were selected and divided into two groups, with 45 cases in each group. The control group was treated with octreotide alone and the observation group was treated with octreotide combined with omeprazole. The therapeutic effect of the two groups was observed. Results The total effective rate was 97.78% in the observation group, which was higher than 80.00% of the control group (P<0.05);The time hospitalization and hemostasis in the observation group were shorter than those of the control group (P<0.05); The rebleeding rate was 2.22% in the observation group, which was lower than 15.55% of the control group (P<0.05). Conclusion efficacy Octreotide and omeprazole in the treatment of upper gastrointestinal hemorrhage in liver cirrhosis patients has definite, which can improve the effective rate, shorten hospitalization and hemostasis time and reduce the inclence of rebleeding.

    KEYWORDS: octreotide; omeprazole; cirrhosis upper gastrointestinal bleeding

    参考文献:
    [1] 邵壮丽,刘全新.奥曲肽注射液治疗肝硬化并上消化道出血的疗效观察[J].贵阳中医学院学报,2013,35(2):179-180.
    [2] 邱美丽,周志坚.奥曲肽联合奥美拉唑治疗上消化道出血64例临床分析[J].中国实用医药,2011,6(18):147-148.
    [3] 李瑞莲.奥曲肽联合奥美拉唑治疗上消化道出血54例[J].中国药业,2014,11(21):105-106.
    [4] 李魏林,余华良.奥曲肽联合奥美拉唑治疗上消化道出血的临床分析[J].中国处方药,2015,13(3):83.
    [5] 李帮永,程宇.46例奥曲肽联合奥美拉唑治疗上消化道出血的疗效观察[J].大家健康(下旬版),2015,10(2):162.
    [6] 刘志玺.奥曲肽联合奥美拉唑治疗上消化道出血效果观察[J].中国社区医师,2014,30(18):45.
    [7] 邱教,项时昊,李访贤.奥美拉唑联合奥曲肽治疗肝硬化上消化道出血82例[J].中国药业,2013,22(5):106.
    [8] 翟攀.奥曲肽联合奥美拉唑治疗肝硬化上消化道出血临床观察[J].实用临床医药杂志,2013,17(5):80-82.
    [9] 阮旭东.奥曲肽联合奥美拉唑治疗肝硬化并上消化道出血[J].中国基层医药,2012,19(18):2781-2782.
    [10] 张健,吴友伟,史丽萍.奥曲肽联合奥美拉唑治疗肝硬化并上消化道出血的疗效评价[J].实用临床医药杂志,2013,17(19):97-99.

上一篇替比夫定联合乙肝疫苗阻断乙肝病毒母婴传播的临床效果分析

下一篇血清超敏C-反应蛋白、肌红蛋白对急性心肌梗死的诊断价值